Clin2
NCT06706752Possibly a fitRecruiting

Shengbai oral formula for chemotherapy side effects

Cancer

Part of Cancer clinical trials.

This study tests if a Chinese herbal formula called Shengbai can safely reduce side effects from chemotherapy. It might help you feel better during cancer treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You have a cancer diagnosis and plan to get at least three rounds of chemotherapy.
  • Your chemotherapy treatments are at least 2 weeks apart.
  • It has been more than 30 days since you had radiation therapy.
  • You are not pregnant and agree to use birth control as your doctor advises.
  • Your doctor expects you to live more than 3 months.
  • You have been taking the same herbal or complementary medicines for the past 30 days and will not start new ones during the study.
  • You can carry out daily activities with little or no help (ECOG score 0–2).
  • You do not have serious liver, kidney, or blood problems.
  • You have not had a bone marrow transplant, brain metastases, or other cancer (except certain skin cancers).
  • You do not have seizures, new heart problems, infections, severe stomach issues, or bleeding disorders.
  • You do not have thyroid disease, lupus, rheumatoid arthritis, or a drug abuse problem.
  • You are not currently in another clinical trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07578064Recruiting· Phase 4
Comparing two treatments for low white blood cells during breast cancer therapy

This study compares two medications—Shengbai Oral Liquid and Leucogen Tablets—to help raise white blood cell counts in breast cancer patients whose counts drop during cancer treatment. Both drugs aim to help your body recover faster and allow you to continue your cancer therapy on schedule.

Shanghai, Shanghai Municipality
NCT06848426Not yet recruiting
Herbal formula plus chemo and immunotherapy for advanced lung cancer

This trial tests a Chinese herbal formula (Xingbai Ji) plus standard chemotherapy and an immunotherapy drug (Sintilimab) for people with advanced lung cancer that lacks common targetable mutations. It's designed for those who haven't had treatment for advanced disease yet.

Nanchang, Jiangxi
NCT06881550Enrolling by invitation
Herbal medicine study for women after breast cancer surgery

This trial tests whether a Chinese herbal medicine (Shenbailing granules) can help improve energy and blood health in women recovering from breast cancer surgery.

Shenyang, Chian/Liaoning
NCT07626528Not yet recruiting· Early Phase 1
Wenyang Tongbi Formula for chemo nerve damage

This trial tests a traditional Chinese herbal medicine called Wenyang Tongbi Formula to treat nerve pain and weakness caused by chemotherapy. If you have breast or colorectal cancer and are experiencing chemotherapy-related nerve damage, this study may help manage your symptoms.

Beijing, Beijing Municipality
NCT07692997Not yet recruiting· Phase 2
Herbal formula for radiation mouth sores

This trial tests a Chinese herbal formula called 'Sancai Fengsui Decoction' to see if it helps heal mouth sores caused by radiation therapy for head and neck cancer. If you are between 18 and 65, have had radiation for head and neck cancer, and have developed these sores, this study may be a good fit.

NCT06214195Recruiting· Phase 3
Shengmai San to prevent heart damage from breast cancer therapy

This trial tests if a traditional Chinese medicine called Shengmai San can protect the heart during chemotherapy and targeted therapy for HER2-positive breast cancer. Patients take the supplement alongside standard treatment to see if it reduces the risk of heart problems.

Hangzhou, Zhejiang

Hear when a new Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.